• Home
    • Concept
  • Program
    • Scientific Chairs
    • Speakers
  • Abstracts
  • Livestream
  • On-demand
  • Partners
  • 2022 Symposia
  • Contacts
    • Data Privacy Policy
    • Legal Notice
  • Location
  • Registration
info@medupdate-europe.eu
Login

Login
Nephro Update Europe 2023Nephro Update Europe 2023
  • Home
    • Concept
  • Program
    • Scientific Chairs
    • Speakers
  • Abstracts
  • Livestream
  • On-demand
  • Partners
  • 2022 Symposia
  • Contacts
    • Data Privacy Policy
    • Legal Notice
  • Location
  • Registration

Partners

At Vifor Pharma, we are dedicated to finding the right treatment solutions for patients. Over several decades, we have proven our ability to identify and serve therapeutic areas with significant unmet medical need, successfully building on our expertise and track record to create new markets.
www.viforpharma.com

Transparency Notes

AMOUNT: 40.000 Euros
CSL Vifor supports the Nephro Update Europe 2023 as Partner.

Watch last year's symposium here for free!

10 Sept. 2022 12.35 - The expanding treatment landscape in AAV and SHPT: lifting the burden of disease - Prof. Brandenburg & Dr. Teng

2021 - The new patient journey: Current and future management approaches to SHPT & CKD-ap - Prof. Wetmore

2021 - The new patient journey: Current and future management approaches to SHPT & CKD-ap - Prof. Buades

2021 - The new patient journey: Current and future management approaches to SHPT & CKD-ap - Q & A

GSK makes innovative vaccines and specialty medicines to prevent and treat disease. Their R&D focuses on the science of the immune system, human genetics and advanced technologies.
www.gsk.com

Transparency Notes

AMOUNT: 30.000 Euros
GSK supports the Nephro Update Europe 2023 as Partner.
Submit an ePoster, registration starting at 150€! Register Here!

Accreditation

The Nephro Update Europe 2023 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

The Nephro Update Europe 2023 has been assessed as COMPLIANT by The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the MedTech Europe Code of Ethical Business Practice.

Endorsement

The Nephro Update Europe 2023 has been endorsed by the ERA. ERA‘s endorsement is for the promotion of education in general, therefore the specific content of the event/course is the responsibility of the organiser.ERA 60 Milan

Follow us

Newsletter Subscription

Click here to receive news about your interest area. Unsubscribe at any time.

ethical medtech

www.ethicalmedtech.eu

© 2023

  • Home
  • Legal Notice
  • Data Privacy Policy
  • Contacts
  • Cookie policy (EU)
Manage Cookie Consent
We use cookies to optimize our website and our service. Please choose, which kind of cookies you'd like to accept.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}